Citation: | YE Lianbao, WU Jieyu, YANG Jiebo, LUO Jiaoyan, HU Qiaohong. Synthesis of the related substances of gefitinib[J]. Journal of China Pharmaceutical University, 2014, 45(6): 667-670. DOI: 10.11665/j.issn.1000-5048.20140608 |
[1] |
AstraZeneca plc(GB).Oncolytic EGF receptor tyrosine kinase inhibitor IressaTM[J].Drugs Future,2002,27(4):339-345.
|
[2] |
Zhang H,Zhao JH,Wang H.Synthesis of 4-(3-chloro-4-fluoro-phenylamineo)-7-methoxy- 6-(3-morpholin-4-yl-propoxy)-quinazoline: CN,200810122242.2[P].2009-04-08.
|
[3] |
Lv TJ,Ouyang QP,Meng XB,et al.Synthesis of gefitinib[J].Guangzhou Chem Ind(广州化工),2010,38(12):154-156.
|
[4] |
Xi YY,Zhang QW.Synthesis of gefitinib[J].Chin J Pharm(中国医药工业杂志),2008,39(6):401-403.
|
[5] |
Xie LH, Ouyang GP. Process Improvement on the synthesis of gefitinib[J].Chin J Synth Chem(合成化学),2010,18(4):523-525.
|
[6] |
Xiao HL,Wang P,Wang YJ,et al.Improved synthesis of gefitinib[J].J Ocean Univ China(中国海洋大学学报),2010,40(8):103-106.
|
[7] |
Jin B,Chen GH,Zhou AF,et al.Synthesis of gefitinib[J].J China Pharm Univ(中国药科大学学报),2005,36(1):92-94.
|
[8] |
Li XS, Zhang AQ, Huang L. Process for the preparation of gefitinib:CN,200910192850.5[P].2009-09-30.
|
[1] | WANG Yongjian, GUO Ming. Design, synthesis and structure-activity relationship of a series of novel BCR-ABL inhibitors[J]. Journal of China Pharmaceutical University, 2024, 55(3): 357-366. DOI: 10.11665/j.issn.1000-5048.2023042302 |
[2] | GUO Wei, XIE Chunwen, WANG Wensheng, ZHENG Deqiang, HE Shuwang. Synthesis of related substances of tebipenem pivoxil[J]. Journal of China Pharmaceutical University, 2018, 49(3): 286-290. DOI: 10.11665/j.issn.1000-5048.20180305 |
[3] | LUO Yan, GU Jinhua, LUO Zhiteng, WU Jie, YE Lianbao. Synthesis of the related substances of deferasirox[J]. Journal of China Pharmaceutical University, 2016, 47(3): 288-290. DOI: 10.11665/j.issn.1000-5048.20160306 |
[4] | YUAN Duo, ZHU Xiong, ZHANG Shijin, WANG Duo, LI Zhiyu, SUN Liping. Analysis and synthesis of the related substances of palbociclib[J]. Journal of China Pharmaceutical University, 2015, 46(6): 696-699. DOI: 10.11665/j.issn.1000-5048.20150610 |
[5] | ZHANG Changqing, FAN Rong, WANG Feng. Synthesis of two related substances of everolimus[J]. Journal of China Pharmaceutical University, 2015, 46(2): 174-177. DOI: 10.11665/j.issn.1000-5048.20150206 |
[6] | WU Mingming, FANG Lei, GOU Shaohua, CHEN Li. 以2-甲基-2-取代苯氧基丙酸为离去基团的铂(Ⅱ)配合物的合成、表征及细胞毒活性[J]. Journal of China Pharmaceutical University, 2013, 44(4): 303-306. DOI: 10.11665/j.issn.1000-5048.20130403 |
[7] | Synthesis of Dopexamine[J]. Journal of China Pharmaceutical University, 1999, (5): 328-331. |
[8] | The Synthesis of Ba m buterol[J]. Journal of China Pharmaceutical University, 1999, (4): 11-12. |
[9] | Synthesis of Oxendolone[J]. Journal of China Pharmaceutical University, 1997, (5): 8-11. |
[10] | Synthesis of Sedative Temazepam[J]. Journal of China Pharmaceutical University, 1997, (4): 11-13. |